Published Oct 25, 2024

20VC: The Truth About Multi-Stage Firms; Why Portfolio Services are for VCs not Founders | Why Politics is Rife & Decision-Making is Broken in Large VCs | Why Reserves are Bad for Founders & How Boutique Firms Will Win with Mark Goldberg @ Chemistry

Mark Goldberg, Managing Partner at Chemistry, delves into the intricacies of multi-stage venture firms, emphasizing the pitfalls of political decision-making and the imperative of building direct relationships with founders. He reveals the strategic advantages of boutique investment approaches and shares personal insights from Chemistry's recent $350M fundraising journey.

Episode Highlights

Topics covered

Questions from this episode

- Tell me something about artificial intelligence
  Asked by 174 people
- What is the current sentiment around the maturation of AI technology?
  Asked by 125 people
- What can we expect in the future of AI?
  Asked by 106 people
- What's the potential impact of AI in the future?
  Asked by 91 people
- Can artificial intelligence transform our lives?
  Asked by 85 people
- What opportunities does AI open up?
  Asked by 84 people
- How does AI change venture capital?
  Asked by 81 people
- How can we integrate AI into our business processes?
  Asked by 78 people
- Do you have any advice from startup founders?
  Asked by 64 people
- What are insights on venture capital?
  Asked by 51 people
- What trends are shaping AI startups?
  Asked by 50 people
- How does artificial intelligence change venture capital?
  Asked by 46 people
- Can venture investing lead to innovation?
  Asked by 45 people
- How are early-stage startups growing?
  Asked by 44 people
- Is venture capital a people business?
  Asked by 43 people

20VC: The Truth About Multi-Stage Firms; Why Portfolio Services are for VCs not Founders | Why Politics is Rife & Decision-Making is Broken in Large VCs | Why Reserves are Bad for Founders & How Boutique Firms Will Win with Mark Goldberg @ Chemistry

Topics covered

Popular Clips

Questions from this episode

Episode Highlights

Venture Capital Dynamics

Investment StrategiesMark Goldberg discusses the decision-making processes at Chemistry and the importance of individual conviction in investments. He also provides insights into current market conditions and the evolving Series A landscape.

Investment Strategies

Fundraising ExperiencesMark Goldberg, Managing Partner at Chemistry, discusses the strategic and empathetic approaches to fundraising for their $350M fund. He shares insights on personal interactions with LPs and the lessons learned from the fundraising process.

Fundraising Experiences

Related Episodes